DocuSign one-pager
In episode #45 of the podcast, we did a deep dive into another one of our model portfolio stocks for 2021, DocuSign. We both have positions in DocuSign in our personal portfolios. Here is a one-pager summarising the key points from our deep dive.
Podcast #46 – Model portfolio Q2 review
It’s time for the half-year review of our model portfolio, a collection of 15 stocks that we selected in January as our core investments for 2021. The sell-off in growth stocks earlier this year made for grim reading at the end of Q1, but many of these stocks have rebounded – ten of the stocks in the model portfolio are now up from our start date, with nine of them beating the market (S&P 500).
Unfortunately, a couple of big losers are dragging down the overall return. While it’s probably too early to declare that “growth is back!”, our portfolio performance at the end of Q2 is much closer to the benchmark of the S&P 500 index. In this episode, we dig into some of the key stories and updates from the portfolio.
Teladoc Health one-pager
Luke and I did a deep-dive into another one of our 2021 model portfolio stocks, Teladoc Health, a leader in telehealth and with their recent merger with Livongo Health, in remote monitoring and digital therapeutics.
CuriosityStream one-pager
In episode 29 of the Telescope Investing Podcast, Luke and I started our search for hypergrowth companies with a deep-dive into a new player in video streaming, CuriosityStream. This one-pager summarises the research that we did, highlighting the key positive and negative points when considering CuriosityStream as a potential investment.